ADVERTISEMENT

Thwarting The Second Wave - Rapid Vaccination Should Be The Primary Tool And Not Lockdown: SBI Research

Thwarting The Second Wave - Rapid Vaccination Should Be The Primary Tool And Not Lockdown: SBI Research

Healthcare workers administer a dose of Bharat Biotech Ltd. Covaxin vaccine for coronavirus at Sanjeevan Hospital in Daryaganj, New Delhi, India. (Photographer T. Narayan/Bloomberg).
Healthcare workers administer a dose of Bharat Biotech Ltd. Covaxin vaccine for coronavirus at Sanjeevan Hospital in Daryaganj, New Delhi, India. (Photographer T. Narayan/Bloomberg).
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More